Impax Laboratories, LLC v. ScieGen Pharmaceuticals, Inc.
| Impax Laboratories, LLC |
| ScieGen Pharmaceuticals, Inc. |
| 1:2025cv01233 |
| October 6, 2025 |
| U.S. District Court for the District of Delaware |
| Gregory B Williams |
| Patent - Abbreviated New Drug Application(ANDA) |
| 35 U.S.C. ยง 1 Patent Infringement |
| None |
Docket Report
RSS Track this Docket
This docket was last retrieved on February 24, 2026. A more recent docket listing may be available from PACER.
| Document Text |
|---|
| Filing 12 Report to the Commissioner of Patents and Trademarks.(lnb) |
Filing 11
SO ORDERED, re #10 Stipulation of Dismissal filed by Impax Laboratories, LLC, ***Civil Case Terminated. Signed by Judge Gregory B. Williams on 2/23/2026. (lnb)
|
| Filing 10 STIPULATION of Dismissal Without Prejudice by Impax Laboratories, LLC. (Levine, James Harry) |
| Pro Hac Vice Attorney Robert Silver for ScieGen Pharmaceuticals, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (jmn) |
|
SO ORDERED, re #8 MOTION for Pro Hac Vice Appearance of Attorney Robert Silver, Esq. filed by ScieGen Pharmaceuticals, Inc. Signed by Judge Gregory B. Williams on 11/18/2025. (lnb)
|
| Filing 9 Pro Hac Vice Fee - Credit Card Payment received for Robert Silver, Esq.. ( re #8 MOTION for Pro Hac Vice Appearance of Attorney Robert Silver, Esq. )( Payment of $ 50, receipt number ADEDC-4839060).(Brown, Charles) |
| Filing 8 MOTION for Pro Hac Vice Appearance of Attorney Robert Silver, Esq. - filed by ScieGen Pharmaceuticals, Inc.. (Brown, Charles) |
| Filing 7 NOTICE of Appearance by Charles J. Brown, III on behalf of ScieGen Pharmaceuticals, Inc. (Brown, Charles) |
|
SO ORDERED, re #6 STIPULATION TO EXTEND TIME time for Defendant to answer, move, or otherwise plead in response to Plaintiff's Complaint to January 12, 2026 filed by Impax Laboratories, LLC, ORDER, Setting Deadlines: All Defendants. Signed by Judge Gregory B. Williams on 10/28/2025. (lnb)
|
| Filing 6 STIPULATION TO EXTEND TIME time for Defendant to answer, move, or otherwise plead in response to Plaintiff's Complaint to January 12, 2026 - filed by Impax Laboratories, LLC. (Levine, James Harry) |
| Case Assigned to Judge Gregory B. Williams. Please include the initials of the Judge (GBW) after the case number on all documents filed. (alb) |
| Filing 5 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Amneal Pharmaceuticals LLC, Other Affiliate Amneal Pharmaceuticals, Inc. for Impax Laboratories, LLC filed by Impax Laboratories, LLC. (scs) |
| Filing 4 Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 8,557,283; 9,089,608; 9,463,246; 9,533,046 ; 9,901,640. (scs) |
| Filing 3 Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: August 28, 2025. Date of Expiration of Patent: December 26, 2028.Thirty Month Stay Deadline: 2/28/2028. (scs) |
| Filing 2 Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (scs) |
| Filing 1 COMPLAINT for Patent Infringement filed against ScieGen Pharmaceuticals, Inc. (Filing fee $ 405, receipt number 4806745) - filed by Impax Laboratories, LLC. (Attachments: #1 Exhibit 1, #2 Exhibit 2, #3 Exhibit 3, #4 Exhibit 4, #5 Exhibit 5, #6 Civil Cover Sheet)(scs) |
| No Summons Issued. (scs) |
Access additional case information on PACER
Use the links below to access additional information about this case on the U.S. Court's PACER system. A subscription to PACER is required.
Access this case on the Delaware District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
| Search for this case: Impax Laboratories, LLC v. ScieGen Pharmaceuticals, Inc. | |
|---|---|
| Search News | [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ] |
| Search Web | [ Unicourt | Legal Web | Google | Bing | Yahoo | Ask ] |
| Plaintiff: Impax Laboratories, LLC | |
| Represented By: | James Harry Stone Levine |
| Search News | [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ] |
| Search Finance | [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ] |
| Search Web | [ Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ] |
| Defendant: ScieGen Pharmaceuticals, Inc. | |
| Represented By: | Robert Silver |
| Represented By: | Charles J. Brown, III |
| Search News | [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ] |
| Search Finance | [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ] |
| Search Web | [ Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ] |
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
